Archive of upcoming and past events related with the nanomedicine community or with participation of ETPN.

Start: Jun 14, 2021 - 2:00 pm
End: Jun 16, 2021 - 6:00 pm
Venue:Virtual event
Event website:

Advancing Measurement Technologies and Standards for Nanomedicine

Nanomedicines and nano delivery systems are employed to deliver therapeutic agents to specific targeted sites in a controlled manner. Although nano drug delivery systems that cover a diverse range have been a research hotspot for a number of years, recent success in lipid nanoparticle technology that allow delivery of nucleic acids intracellularly have placed nanomedicine at the centre stage.

The availability of robust and validated analytical methods and formally recognised consensus standards continue to lag, slowing progress and complicating the regulatory process. The objective of this workshop is to coming together on efforts to develop, validate and apply new measurement methods and standards for nano-enabled medical products, with a particular emphasis on lipid-based technologies.


The intent of the workshop is to provide a virtual platform for industry, regulatory, and research scientists to discuss recent advances and practical challenges, and to identify and prioritise specific measurement and standards needed to facilitate preclinical development and regulatory approval moving forward.

*The chairs welcome broad participation from industry, regulators, and government or academic researchers.

Please note: recordings of the event will not be made available and registration is encouraged for all those who wish to participate.

Workshop agenda

The meeting will take place on-line over three half day sessions, 14-16 June, 2021, with the following themes:

14 June: Nanomedicine – technology and applications
15 June: Regulatory science issues and perspectives
16 June: Standards and measurement development

Each day’s workshop will last for approximately 4 hours, with a combination of presentations and moderated panel discussion. Sessions will begin each day as below:

Download Draft Agenda by clicking here


Session Focus


Monday 14 June

Technology and applications

  • BST: 13:00 – 17:10 (London)
  • CET: 14:00 – 18:10 (Berlin)
  • EDT: 08:00 – 12:10 (New York)
  • PT: 05:00 – 9:10 (Los Angeles)

Tuesday 15 June

Regulatory perspectives

As above

Wednesday 16 June

Standards and measurements

As above

For other time zones, please note start time Coordinated Universal Time UTC is 12:00

Workshop presenters include

  • Marianne Ashford (AstraZeneca)
  • Anil Patri (FDA, USA)
  • Dean Ripple (NIST, USA)
  • Kate Arnot (AstraZeneca)
  • Fanny Caputo (SINTEF, Norway & chair of the ETPN WG on Safety & Characterization)
  • Jeffrey Clogston (NCL, USA)
  • Adam Crowe (Precision Nanosystems Inc., Canada)
  • Emiliana de Santis (NPL, UK)
  • Marina Dobrovolskaia (NCL, USA)
  • Scott McNeil (University of Basel, Switzerland)
  • Dora Mehn (EC JRC)
  • Yvonne Perrie (University of Strathclyde, UK)
  • Chris Tam (Integrated Nanotherapeutics, Canada)
  • Rene Thürmer (BfArM, Germany)
  • Xiaoming Xu (FDA/CDER, USA)
  • Qin Zou (Pfizer, USA)
  • Shan Zou (NRC, Canada)

Meeting chairs

  • Caterina Minelli (NPL, UK)
  • Nadim Akhtar (AstraZeneca)
  • Luigi Calzolai (EC JRC)
  • Vince Hackley (NIST, USA)



About the NPL

NPL - Project Membership - MetroMRTNPL is the UK’s National Metrology Institute, developing and maintaining the national primary measurement standards.It is a Public Corporation owned by the Department of Business, Energy and Industrial Strategy (BEIS). It has a partnering agreement with BEIS and the University of Strathclyde and the University of Surrey. NPL is part of the National Measurement System (NMS) which provides the UK with a national measurement infrastructure and delivers the UK Measurement Strategy on behalf of BEIS.

We undertake excellent science and engineering to deliver extraordinary impact for the UK and provide the measurement capability that underpins the UK’s prosperity and quality of life. From accelerating new antibiotics and more effective cancer treatments to developing unhackable quantum communications and superfast 5G, our expertise is crucial in researching, developing and testing new products and processes.